Cargando…

Interpreting patient-reported outcomes from clinical trials in COPD: a discussion

One of the challenges faced by the practising physician is the interpretation of patient-reported outcomes (PROs) in clinical trials and the relevance of such data to their patients. This is especially true when caring for patients with progressive diseases such as COPD. In an attempt to incorporate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Paul W, Rennard, Stephen, Tabberer, Maggie, Riley, John H, Vahdati-Bolouri, Mitra, Barnes, Neil C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153282/ https://www.ncbi.nlm.nih.gov/pubmed/27994447 http://dx.doi.org/10.2147/COPD.S117378

Ejemplares similares

Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD
por: Singh, Sally, et al.
Publicado: (2018)

A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD
por: Rheault, Tara, et al.
Publicado: (2016)

Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials
por: Riley, John H, et al.
Publicado: (2016)

Creating scenarios of the impact of copd and their relationship to copd assessment test (CAT™) scores
por: Jones, Paul W, et al.
Publicado: (2011)

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD
por: Feldman, Gregory, et al.
Publicado: (2016)

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial
por: Maltais, François, et al.
Publicado: (2019)

Influence of diet and obesity on COPD development and outcomes
por: Hanson, Corrine, et al.
Publicado: (2014)

Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life
por: Tabberer, Maggie, et al.
Publicado: (2018)

Icenticaftor, Novel Therapy for COPD: This Glass Is Half Full
por: Rennard, Stephen I.
Publicado: (2023)

Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial
por: Ismaila, Afisi S., et al.
Publicado: (2017)

Discussion about data interpretation
por: Read, Alexander
Publicado: (2011)

Discussion Required for Correct Interpretation
por: Bukowski, Radek, et al.
Publicado: (2006)

Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design
por: Worsley, Sally, et al.
Publicado: (2019)

A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease
por: Tabberer, Maggie, et al.
Publicado: (2015)

Preventing clinically important deterioration with single-inhaler triple therapy in COPD
por: Naya, Ian, et al.
Publicado: (2018)

Beyond the bins: interpreting and discussing pharmacogenomic reports with psychiatric patients
por: Dunlop, Boadie W.
Publicado: (2020)

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
por: Halpin, David M.G., et al.
Publicado: (2021)

Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study
por: Singh, Dave, et al.
Publicado: (2010)

Updated Perspectives on the Role of Biomechanics in COPD: Considerations for the Clinician
por: Yentes, Jennifer M, et al.
Publicado: (2022)

Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trials
por: Król, Agnieszka, et al.
Publicado: (2020)

The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world
por: Barnes, Neil, et al.
Publicado: (2018)

Sexually-dimorphic targeting of functionally-related genes in COPD
por: Glass, Kimberly, et al.
Publicado: (2014)

Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study
por: Fahy, William A, et al.
Publicado: (2021)

Measuring respiratory symptoms in moderate/severe asthma: evaluation of a respiratory symptom tool, the E-RS®: COPD in asthma populations
por: Tabberer, Maggie, et al.
Publicado: (2021)

Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review
por: Contopoulos-Ioannidis, Despina G, et al.
Publicado: (2009)

Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care
por: Müllerová, Hana, et al.
Publicado: (2014)

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
por: Tabberer, Maggie, et al.
Publicado: (2020)

Changing the Way We Report, Interpret, and Discuss Our Results to Rebuild Trust in Our Research
por: Bernard, Christophe
Publicado: (2019)

Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey
por: Müllerová, Hana, et al.
Publicado: (2016)

Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
por: Rennard, Stephen I, et al.
Publicado: (2011)

COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population
por: Fletcher, Monica J, et al.
Publicado: (2011)

Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD
por: Mitzel, Holly, et al.
Publicado: (2022)

Fundamental Outcome Measurement: Selecting Patient Reported Outcome Instruments and Interpreting the Data they Produce
por: McKenna, Stephen P, et al.
Publicado: (2021)

Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement
por: Jones, Paul, et al.
Publicado: (2012)

Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps
por: Afroz, Nuzhat, et al.
Publicado: (2020)

Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review
por: Cordoba, Gloria, et al.
Publicado: (2010)

The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial
por: Patel, Naimish R, et al.
Publicado: (2018)

Implementing lessons learned from previous bronchial biopsy trials in a new randomized controlled COPD biopsy trial with roflumilast
por: Barnes, Neil C, et al.
Publicado: (2014)

Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD
por: Calverley, Peter M. A., et al.
Publicado: (2016)

Analyzing networks of phenotypes in complex diseases: methodology and applications in COPD
por: Chu, Jen-hwa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8g894dkcht74lr510ds2e919r6